Nanjing Daoqun Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NANJING DAOQUN, and what generic and branded alternatives to NANJING DAOQUN drugs are available?
NANJING DAOQUN has one approved drug.
Summary for Nanjing Daoqun
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Nanjing Daoqun
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nanjing Daoqun | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 217133-001 | Oct 30, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Nanjing Daoqun | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 217133-002 | Oct 30, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
